Impact Analytical Expands Michigan Facility
Impact Analytical's facility in Michigan adds staff and instrumentation.
Impact Analytical’s new facility, located in Midland, Mich., has added $200,000 in instrumentation and brought on several additional analytical and business development experts to support its testing services since its opening in June 2013.
The new instrumentation gives Impact the opportunity to strengthen its core capabilities, including ICP-MS to comply with new USP methods (<232> and <233>) for heavy metals, ion chromatography, an ASE extractor for use in extractables and leachables studies, and a LC-MS Q-TOF system with exact mass capabilities.
The new site includes 35 scientists who operate more than 80 instruments in six areas, including elemental analysis, gas separation, liquid separation, microscopy, molecular characterization, and thermal and mechanical properties.
Source: Impact Analytical
Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance
April 2nd 2025Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
